Clinical Trial Update: Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative Colitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating intravenous vedolizumab in Chinese participants with moderately to severely active ulcerative colitis; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Moderately to Severely Active Ulcerative Colitis | Phase 3 | Status: RECRUITING